Your browser doesn't support javascript.
loading
Immune reactivity of two biological models to vaccination with inactivated vaccine QazVac against coronavirus infection COVID-19.
Myrzakhmetova, B S; Zhapparova, G A; Bisenbayeva, K B; Toytanova, A S; Tuyskanova, M S; Zhugunissov, K D; Kutumbetov, L B.
Affiliation
  • Myrzakhmetova BS; Research Institute for Biological Safety Problems.
  • Zhapparova GA; Research Institute for Biological Safety Problems.
  • Bisenbayeva KB; Research Institute for Biological Safety Problems.
  • Toytanova AS; Research Institute for Biological Safety Problems.
  • Tuyskanova MS; Research Institute for Biological Safety Problems.
  • Zhugunissov KD; Research Institute for Biological Safety Problems.
  • Kutumbetov LB; Research Institute for Biological Safety Problems.
Vopr Virusol ; 69(3): 219-230, 2024 Jul 05.
Article de En | MEDLINE | ID: mdl-38996371
ABSTRACT

INTRODUCTION:

Specific prevention of a number of infectious diseases has been introduced into the vaccination schedule. The production of immunoprophylactic drugs, in order to establish standard properties, including safety and specific effectiveness, requires strict adherence to manufacturing regulations, and the reliability of the results obtained requires monitoring of these parameters. The specific effectiveness of vaccine preparations is standardized according to the indicators of stimulation of specific antibody response formed in the body of vaccinated model biological objects.

OBJECTIVE:

Determination of the immune reactivity of white mice to vaccination with the QazVac vaccine to establish the possibility of using them as a biological model in assessing the immunogenicity of the vaccine instead of Syrian hamsters. MATERIALS AND

METHODS:

The immune reactivity of model animals was assessed by the seroconversion rate, dynamics of antibody titers to the SARS-CoV-2 virus formed in the body after vaccination with the test vaccine. In the case of seropositivity of animals before administration of vaccine or placebo, the level of immune reactivity was calculated by the difference in antibody titers between control and vaccinated animals or by the difference in antibody titers before and after immunization. Specific antibodies were detected and their titer was determined using a neutralization reaction.

RESULTS:

The research results showed that the tested biological models had approximately the same immune reactivity to the administration of the QazVac vaccine, confirmed by the level and dynamics of antibody titers. When analyzing the fold increase in antibody titers in comparison to those of control animals, Syrian hamsters were more reactive compared to mice. But SPF white mice were standardized in their lack of the immune reactivity to SARS-CoV-2 virus before the immunization.

CONCLUSION:

The data obtained indicate that the immune reactivity of white mice to the administration of the QazVac vaccine in terms of the rate and dynamics of the formation of virus-neutralizing antibodies is approximately equivalent to the immune reactivity of Syrian hamsters. Before immunization with the vaccine, SPF white mice, in contrast to Syrian hamsters, do not have humoral immunity specific to the SARS-CoV-2 virus. The immune reactivity equivalent to that observed of Syrian hamsters and the absence of antibodies to the SARS-CoV-2 virus at a baseline indicate the superiority of the use of white mice in assessing the immunogenicity of vaccines against COVID-19 and/or obtaining specific factors of humoral immunity.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins inactivés / Vaccination / Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Anticorps antiviraux Limites: Animals / Female / Humans Langue: En Journal: Vopr Virusol Année: 2024 Type de document: Article Pays de publication: Russie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins inactivés / Vaccination / Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Anticorps antiviraux Limites: Animals / Female / Humans Langue: En Journal: Vopr Virusol Année: 2024 Type de document: Article Pays de publication: Russie